Interactive Brokers Advertisement
Home > Boards > US OTC > Medical - Healthcare >

Cord Blood America Inc. (CBAI)

Add CBAI Price Alert      Hide Sticky   Hide Intro
Moderator: Myth, boardbrain1, locksflooring, Agent92260, junkHustler, Termite7
Search This Board: 
Last Post: 6/23/2017 3:44:28 PM - Followers: 433 - Board type: Free - Posts Today: 0

Cord Blood America

(This "Intro Box" is NOT maintained by Cord Blood America and is intended solely as a quick information source on ihub.  For more detailed, up-to-date information on Cord Blood America,  please go the company website by clicking the link above..)

Company Summary

Cord Blood America, Inc.(CBAI), through its wholly owned subsidiary CorCell Companies, Inc., is engaged in the business of collecting, testing, processing and preserving umbilical cord blood, thereby allowing families to preserve cord blood at the birth of a child for potential use in future stem cell therapy.

The umbilical cord which, at birth, traditionally has been thrown away, contains a rich store of stem cells. Cryogenically preserved umbilical cord stem cells have already been used to treat 75 major diseases, including leukemia, severe anemia, metabolic blood disorders and immune deficiencies. This list is guaranteed to grow as medical research learns more about the incredible healing power of stem cells.

There is uniformity in the belief that stem cells will play a key role in fighting disease as we move forward through this century. Some scientists are confident that stem cells will launch a new era in medicine, perhaps even curing some of our most intractable diseases.

Cord Blood America's Competitive Edge

CBAI offers extensive experience, with over 16 years in the cord blood banking industry, a proven processing model, technology and all the assistance our business to business clients need to grow their cord blood banking company without the additional cost of operating their own laboratory. CBAI is licensed in New Jersey, New York, California and Maryland and registered with the FDA.  They are also a Clinical Laboratory Improvement Amendments (CLIA) certified laboratory. 

Cord Blood America's state of the art laboratory is located minutes from McCarran International Airport in Las Vegas, NV; with approximately 3,300 inbound flights per week they are able to receive  customer samples 24/7/365.  Cord Blood America is a fully licensed cord blood bank that has processed more than 27,000 cord blood units since first opening in 1996. The 17,000-square-foot facility is equipped with the most advanced processing and storage technologies. The facility is under 24 hour surveillance with stringent restricted access protocols your client's cord blood unit will be kept at the correct temperature at all times thanks to our 24 hour monitoring system.

The Tissue Bank Director had more than 25 years of experience in the stem cell field.  A staff of highly experienced health professionals and technicians, working under the guidance and expertise of CBAI's Scientific/Medical Advisory Panel of industry leaders, offers both technical skill and unparalleled leadership. This unique combination of talents ensures that the laboratory remains on the cutting-edge of new cord blood advances, while guarenteeing the safety, integrity and viability of your customer's cord blood unit.

  News      Partnerships   Company History  Executive Team
Lab       SEC Filings    Videos                       Contacts

LAS VEGAS, May 15, 2012 /PRNewswire/ -- Cord Blood America, Inc. ( (OTC BB: CBAI), the umbilical cord blood stem cell preservation company focused on bringing the life saving potential of stem cells to families nationwide and internationally, today announced that, effective May 14, 2012, Matthew Schissler has resigned his position as Chairman, CEO, and Secretary, and as a Director of Cord Blood America.  Mr. Schissler is also no longer an officer or director with any of the Company's wholly owned subsidiaries. 

Joseph R. Vicente, who had been Chief Operating Officer and Vice President of the Company prior to May 15th, was appointed Chairman and President by the Board of Directors on May 15th.  Mr. Vicente joined the Company as a Director of Cord Blood America in April 2004.  He previously served as an independent consultant to companies, providing strategic consulting services on acquisitions, operational practices and efficiencies and sales management.  Mr. Vicente, who earned an MBA from the University of Tampa, has also held various executive positions with profit and loss responsibility for System One/TMP Worldwide, Inc.

The Board of Directors on May 15th also named Stephen Morgan as the Company's Vice President and Secretary.  He has served as General Counsel for the Company since August 2010 and will also remain in that role.  A graduate of Loyola Law School in Los Angeles, prior to working for the Company Mr. Morgan represented clients in a broad range of transactional and litigation matters working for law firms in the Los Angeles area.

Share Structure

Oct 2013, 890,000,000 
June 2013, 878,405,849 from page 24 

Transfer Agent:  Interwest Transfer Co.  (801) - 272-9294

AS:   895M
OS: 624,192,183 3-15-2013
OS:  249,999,364  12-31-2011 (as per 10K)
OS:  107,448,896  10-17-2011 (as per S1/A)
OS:  101,018,608  09-30-2011 (as per 10Q)
OS:   91,471,696  08-31-2011 (as per S-1/A)
OS:   81,762,984 08-29-2011 (as per SG-13)
OS:   70,895,400  06-30-2011 (as per Q2)
OS:   68,128,866  05-10-2011 (as per Q1) (after reverse split on 5/9/2011)
OS:  6,815,696,764 as of 03/13/11 (source: 03/13/11 10k -- 1.123B added in the last 4 mos)
OS:  5,692,564,026 as of 11/09/10 (source: 09/30/10 10Q -- 419M added in the last 3 mos)
OS:  5,273,093,131 as of 08/09/10 (source: 06/30/10 10Q -- 195M added in the last 5 mos)
OS:  5,078,132,870 as of 03/24/10 (source:03/31/10 10K -- 192M added in the last 3 mos)
OS:  4,886,468,478 as of Dec 31, 2009 (per 12/31/09 S-1  -- 318M added in the last 50days )
OS:  4,568,253,327 as of Nov 09, 2009 (per  11/03/09 10Q -- 1.95B added in the last 3 mos)
OS:  2,611,087,327 Aug 10, 2009 (per 8/14/09 10Q -- 1.03B added in the last 3 mos)
OS: 1,579,096,424 May 15, 2009 (per 10Q -- 636M added in the last 3 mos)
OS: 942,884,111 Feb 12, 2009 (per proxy statement -- 634M added in the last 3 mos) - Most of this has been sold through mm NITE & HDSN
OS: 309,474,243 Nov 10, 2008 (per 10Q -- 85M added in the last 4 mos)
OS: 224,699,718 Jul 08, 2008 (per 8/04/08 proxy statement)
OS: 225,154,440 Apr 07, 2008 (per 10k, --30M added in the last 4 months)
OS: 195,558,923 Dec 31, 2007 +21M)
OS: 174,048,335 Nov 11, 2007  +9M)
OS: 165,372,807 Sept 30, 2007 +6M)
OS: 159,055,819 Aug 14, 2007 +73M)
OS: 85,565,249 May 18, 2007  +37M)
OS: 49,118,075 Apr 02, 2007  +8M)
OS: 41,091,845 Nov 10, 2006


2011: $5,668,482
2010: $4,128,439
2009: $3,237,183
2008: $4,169,949
2007: $5,811,267
2006: $3,328,336
2005: $2,099,463


Cord Blood America, Inc.(CBAI), through its wholly owned subsidiary CorCell Companies, Inc., is engaged in the business of collecting, testing, processing and preserving umbilical cord blood, thereby allowing families to preserve cord blood at the birth of a child for potential use in future stem cell therapy.

NEW CEO The entire interview is available at:

Cord Blood America, Inc "Companies"
- (13 locations)


September 30,2012,-249,999,364====Cash $369,186 Increase
June 30, 2012,-----249,999,364====Cash $332,928 Increase
March 31, 2012,----249,999,364====Cash $300,619 Increase

Assets Over $7million

2012: almost $6million
Share Outstanding= last known 643million with 890 a/s

Operating on its own cash= YES
Cash flow= 369,186

2011: $5,668,482
Operating on it own cash=NO

2010: $4,128,439
Shares outstanding 5.6 Billion shares
$66million market cap
Operating on it own cash= NO
Cash Flow= $236K
New Debt issued= YES

2009: $3,237,183==$30million market cap==

2008: $4,169,949
2007: $5,811,267
2006: $3,328,336
2005: $2,099,463

PR September 26, 2012 commented Joseph Vicente, President of Cord Blood America. "We are now cash flow positive so the announced approval to increase our authorized shares is primarily to fix legacy issues. Operating activities have already shown marked sequential and year over year improvement while reducing corporate costs creating an advantageous time to improve the capital structure and bring the Company to the next level while broadening its appeal to a wider audience of potential investors."

Nine-Months Ended September 30, 2012 Highlights

=====Revenue increase 18% to $4.64 million from $3.93 million in the year ago period.
=====Our cash position increased over 100% to $369,186.
=====Gross margin increased to 72.7% from 70.5% in the year ago period.
=====SG&A decreased 24% or $1.17 million to $3.64 million from $4.81 million.

For the second consecutive quarter, we demonstrated marked improvement in three key performance metrics; revenue growth, expense control and EBITDA. The result is that we have improved our cash position, while reducing the current liabilities without adding to the debt obligations of the Company. We continue to see consistent growth in the number of new customers added each quarter that will layer on top of our existing recurring revenue base. We expect our new customers to have an annual recurring duration of approximately eighteen years demonstrating the significant lifetime value of each new client," commented Joseph Vicente, President of Cord Blood America, Inc.

Share Structure

Projected SS:: Since September 30 2012 1.117 Billion shares have traded, based on statistics from the past 65% of shares trades would contribute to the outstanding = 726 Million shares outstanding as/of 03/13/2013 which

Finally, CBAI's President said that although the Company's financial situation has improved and the Company did not take any additional financing in Q2, it is not generating enough cash to pay off its entire debt balance. He urged shareholders to approve an increase in the number of authorized shares "as a means to retire out legacy debt and move forward."

Insurance Partners

Blue Cross Blue ShieldOur current healthcare partners listed below have negotiated a special program for our customers to save cord blood for their children, grandchildren, nieces, nephews, friends or other loved ones. To learn more about our insurance partners visit the CorCell® website at

Blue Cross of Idaho's

AmeriHealth Administrators
Asuris Northwest Health
Blue Cross Blue Shield of Kansas
Blue Cross Blue Shield of Northeastern Pennsylvania
Highmark Inc.
Highmark Blue Cross Blue Shield West Virginia
HMSA - Blue Cross Blue Shield of Hawaii
Horizon Blue Cross Blue shield of New Jersey
Independence Administrators
Independence Blue Cross
Keystone, Personal Choice (part of IBC, and BCBS of North Eastern PA)
LifeWise Assurance Company
LifeWise Health Plan of Oregon
LifeWise Health Plan of Washington
Premera Blue Cross
Permera Blue Cross Blue Shield of Alaska
Regence Blue Shield
Regence BlueCross Blue Shield of Oregon
Regence BlueCross Blue Shield of Utah
Regence BlueCross Blue


Joe has been a Director of Cord Blood America since April 2004. Additionally, he currently serves as the President. Prior to joining us Joe was an independent consultant where he provided strategic consulting services to organizations on acquisitions, operational practices and efficiencies, and sales management. He was a Senior Vice President at TMP Worldwide, Inc. where he held various positions with profit and loss responsibility.

Joe graduated from Bowling Green State University with a BSBA and from University of Tampa with an MBA.

Joseph Vicente Primarily involved in Mergers & Acquisitions, Corporate Governance
(702) 914-7250

The entire interview is available at:

Vice President & General Counsel

Stephen Morgan
Stephen Morgan currently serves as Vice President, General Counsel, and Secretary. He has been General Counsel of the Company since August 2010. Prior to his employment with the Company, Mr. Morgan worked for law firms in Los Angeles, California, representing clients in a broad range of transactional and litigation matters. Mr. Morgan earned his Bachelor of Science degree from the University of Minnesota and his Juris Doctor from Loyola Law School in Los Angeles, California.

(702) 914-7250

Tissue Bank Director

Dr. O'Neill has 25 years experience in the industry, processed more than 50,000 specimens and has published 78 papers. Educated at the University of Glasgow in Scotland, Dr. O'Neill came to the United States in 1979 to work for the Memorial Sloan-Kettering Cancer Center in New York. While continuing to work in the field his experience continued to grow as he also was a Professor at various prestigious universities including:

Cornell University school of Medicine, NY;
Columbia University, NY;
Visiting Professor at the Institute of Immunology in Munich

Dr. Geoffrey O'Neill
(702) 914-7250

more pictures :::

6 Month Chart



Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
CBAI News: Additional Proxy Soliciting Materials (definitive) (defa14a) 05/31/2017 02:02:31 PM
CBAI News: Proxy Statement (definitive) (def 14a) 05/30/2017 02:08:05 PM
CBAI News: Current Report Filing (8-k) 05/15/2017 08:17:37 AM
CBAI News: Quarterly Report (10-q) 05/15/2017 08:05:50 AM
CBAI News: Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a) 05/08/2017 12:04:05 PM
#97425  Sticky Note the devil has a face stallion 01/16/16 04:59:24 PM
#92481  Sticky Note Cord Blood America Announces Equity Investment by Red Myth 04/10/15 09:27:16 AM
#101968   Haha, yes, that's gonna help nobody. I just Agent92260 06/23/17 03:44:28 PM
#101967   Ok great, give me a valuation based on MoneyMan 06/23/17 03:39:33 PM
#101966   If you say so, but repeating it doesn't Agent92260 06/23/17 03:31:49 PM
#101965   Agree, this is fairly valued right here. The MoneyMan 06/23/17 03:29:19 PM
#101964   Haha, with that logic everything in the market Agent92260 06/23/17 03:27:30 PM
#101962   If you say so. Agent92260 06/23/17 03:18:03 PM
#101961   So it is not worth buying in the MoneyMan 06/23/17 03:16:33 PM
#101960   I don't follow your logic. I never said Agent92260 06/23/17 03:14:57 PM
#101959   So it is not worth .003's? Great, that MoneyMan 06/23/17 03:13:19 PM
#101958   Please, please, please dump into the .002's! Agent92260 06/23/17 01:29:32 PM
#101956   keeping track of my buys, very good ! Myth 06/23/17 06:32:30 AM
#101955   Big bucks $150 less commission. WOW TONYM 06/22/17 03:21:17 PM
#101954   Looks like some nice dumping today. Right back MoneyMan 06/22/17 02:26:22 PM
#101953   Dilution, and shareholder dumping results in much of Myth 06/21/17 03:34:59 PM
#101952   Wow, look at the volume on this one...... MoneyMan 06/21/17 03:28:15 PM
#101951   Agreed. No sellers either! Agent92260 06/20/17 04:18:16 PM
#101950   That's great, a sure sign of no dilution.... Myth 06/20/17 03:50:08 PM
#101949   another good call TONYM 06/20/17 01:59:14 PM
#101948   LoL @ ZERO trades!!!! Termite7 06/20/17 01:39:13 PM
#101947   Yes, i see what you mean, i like mind1 06/20/17 12:21:00 PM
#101946   Hope so, i always favored CBAI as a mind1 06/20/17 11:47:47 AM
#101945   That's good to hear, thanks... Myth 06/20/17 11:10:18 AM
#101944   Yep, the campaign I'm seeing is more professional, Agent92260 06/20/17 11:08:58 AM
#101943   That's interesting, as far as their intentions, what Myth 06/20/17 11:03:58 AM
#101942   Only 425,000 shares traded at .0029? A thousand MoneyMan 06/20/17 11:03:23 AM
#101941   Somebody wants to grow CBAI, Corcell's social media Agent92260 06/20/17 10:31:36 AM
#101940   Just wondering,the assumption is that CBAI will eventually mind1 06/19/17 08:07:39 PM
#101939   So what, there was selling today. So what? mind1 06/19/17 07:29:46 PM
#101937   Nice dumping ROD. MoneyMan 06/19/17 06:20:09 PM
#101936   Looks to me the MM's are keeping the mind1 06/19/17 04:01:23 PM
#101935   lol......don't worry, it will happen..... Myth 06/19/17 03:58:13 PM
#101934   Haha, you're in my way. I'm sitting at Agent92260 06/19/17 03:53:12 PM
#101933   I'm back @ .0029..... Myth 06/19/17 03:50:17 PM
#101932   .0002 x .0003 almost????????? TONYM 06/16/17 04:57:31 PM
#101931   YUP THAT SCUMBAG JOE V HAD NO CLUE locksflooring 06/16/17 04:17:28 PM
#101930   $0.0032 looks like $0.0002_X_$0.0003 ......almost! ;-) Termite7 06/16/17 02:50:56 PM
#101929   whats going on little movement here anything big REDZONE 06/16/17 01:07:28 PM
#101928   Oh yeah a whole 800,000 shares philly1 06/15/17 08:31:10 PM
#101927   Nice dumping today. MoneyMan 06/15/17 06:13:25 PM
#101926   Excellent, I'm waiting on the bid now with Agent92260 06/15/17 02:23:15 PM
#101925   Dumping continues as the bid is sinking.... MoneyMan 06/15/17 02:07:14 PM
#101924   That's better than what the previous morons knew, Myth 06/15/17 01:05:44 PM
#101922   WRONG IT'S ALL IN THE FILINGS, THE DD locksflooring 06/14/17 04:07:05 PM
#101921   WRONG HE DOESNT KNOW STEM CELLS AND BARELY locksflooring 06/14/17 04:05:12 PM
#101920   WHEN HE BARLEY KNOWS LAW Myth 06/13/17 06:34:13 PM
#101919   There's no truth to any of that.... Myth 06/13/17 06:30:24 PM
#101918   WAIT WAIT WAIT! WE ALLLLLLLLL CAN SUPPOSEDLY SEEEEEEEEEEE locksflooring 06/13/17 04:48:09 PM
#101917   WE ALREADY KNOW CBAI ISNT STORING ANYMORE SAMPLES locksflooring 06/13/17 04:43:25 PM
#101916   lol...I highly doubt the SEC is worried about Myth 06/13/17 04:40:48 PM
#101915   The share count is revealed in every SEC Myth 06/13/17 04:38:57 PM